Total Payments
$35,140
2024 Payments
$157.57
Companies
43
Transactions
242
Medicare Patients
1,502
Medicare Billing
$160,426
Payment Breakdown by Category
Gifts$20,739 (59.0%)
Food & Beverage$7,017 (20.0%)
Consulting$3,960 (11.3%)
Other$1,700 (4.8%)
Travel$1,570 (4.5%)
Education$153.45 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $20,739 | 1 | 59.0% |
| Food and Beverage | $7,017 | 229 | 20.0% |
| Consulting Fee | $3,960 | 2 | 11.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,700 | 2 | 4.8% |
| Travel and Lodging | $1,570 | 5 | 4.5% |
| Education | $153.45 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $23,580 | 27 | $0 (2020) |
| JAZZ PHARMACEUTICALS INC. | $5,285 | 9 | $0 (2023) |
| AbbVie Inc. | $634.27 | 24 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $523.61 | 31 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $458.23 | 11 | $0 (2018) |
| Eisai Inc. | $451.80 | 7 | $0 (2018) |
| GENZYME CORPORATION | $444.54 | 14 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $393.38 | 17 | $0 (2019) |
| EMD Serono, Inc. | $383.24 | 7 | $0 (2021) |
| Lilly USA, LLC | $261.29 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.57 | 2 | Lilly USA, LLC ($82.96) |
| 2023 | $5,893 | 21 | JAZZ PHARMACEUTICALS INC. ($5,285) |
| 2022 | $1,028 | 23 | Alexion Pharmaceuticals, Inc. ($179.34) |
| 2021 | $332.95 | 5 | EMD Serono, Inc. ($129.82) |
| 2020 | $2,683 | 9 | Allergan, Inc. ($2,683) |
| 2019 | $21,664 | 48 | Allergan Inc. ($20,749) |
| 2018 | $1,437 | 29 | Eisai Inc. ($409.63) |
| 2017 | $1,945 | 105 | Teva Pharmaceuticals USA, Inc. ($374.78) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 3 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $99.97 | General |
| Category: PRIMARY CARE | ||||||
| 05/26/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $362.30 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $161.22 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $150.92 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $93.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $50.24 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $40.21 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $124.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $61.96 | General |
| Category: Central Nervous System | ||||||
| 11/01/2019 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Cardiology | ||||||
| 10/21/2019 | GENZYME CORPORATION | AUBAGIO (Drug), LEMTRADA | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/15/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Neuroscience | ||||||
| 09/11/2019 | GENZYME CORPORATION | AUBAGIO (Drug), LEMTRADA | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 09/09/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Central Nervous System | ||||||
| 09/09/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: Central Nervous System | ||||||
| 07/15/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/12/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Central Nervous System | ||||||
| 07/12/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: Central Nervous System | ||||||
| 07/10/2019 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $23.32 | General |
| Category: Immunology | ||||||
| 06/19/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/17/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $100.89 | General |
| Category: OCULAR | ||||||
| 06/14/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 437 | 516 | $237,513 | $44,248 |
| 2022 | 6 | 605 | 683 | $329,420 | $68,246 |
| 2021 | 7 | 275 | 312 | $138,296 | $32,705 |
| 2020 | 6 | 185 | 235 | $43,083 | $15,228 |
Total Patients
1,502
Total Services
1,746
Medicare Billing
$160,426
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 303 | $129,684 | $24,151 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $49,662 | $9,745 | 19.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 54 | $32,400 | $5,851 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $15,477 | $3,137 | 20.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 34 | 49 | $10,290 | $1,364 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 250 | $106,000 | $22,485 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 160 | 160 | $88,640 | $17,486 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 79 | 79 | $57,828 | $12,767 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 70 | $41,860 | $9,110 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 100 | $30,100 | $5,516 | 18.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 18 | 24 | $4,992 | $882.00 | 17.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 84 | 84 | $46,788 | $10,155 | 21.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 52 | 52 | $35,152 | $8,917 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 41 | 70 | $24,368 | $6,375 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 32 | $13,792 | $3,134 | 22.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 46 | $13,938 | $3,047 | 21.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 12 | $2,937 | $770.64 | 26.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 16 | 16 | $1,320 | $304.50 | 23.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 60 | 79 | $10,520 | $5,525 | 52.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 70 | 94 | $7,758 | $4,182 | 53.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $10,903 | $3,007 | 27.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 18 | $4,323 | $1,167 | 27.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 14 | $6,776 | $1,005 | 14.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 12 | 13 | $2,802 | $342.13 | 12.2% |
About Dr. Robert Egan, MD
Dr. Robert Egan, MD is a Neuro-ophthalmology healthcare provider based in Medford, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396771358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Egan, MD has received a total of $35,140 in payments from pharmaceutical and medical device companies, with $157.57 received in 2024. These payments were reported across 242 transactions from 43 companies. The most common payment nature is "Gift" ($20,739).
As a Medicare-enrolled provider, Egan has provided services to 1,502 Medicare beneficiaries, totaling 1,746 services with total Medicare billing of $160,426. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuro-ophthalmology
- Other Specialties Neurology, Neurology
- Location Medford, OR
- Active Since 06/23/2006
- Last Updated 06/20/2022
- Taxonomy Code 207WX0109X
- Entity Type Individual
- NPI Number 1396771358
Products in Payments
- BOTOX (Biological) $20,749
- EPIDIOLEX (Drug) $5,285
- UBRELVY (Drug) $2,846
- Fycompa (Drug) $451.80
- COPAXONE (Drug) $348.95
- NUEDEXTA (Drug) $321.95
- QULIPTA (Drug) $273.18
- Rebif (Biological) $243.08
- GILENYA (Drug) $233.18
- XCOPRI (Drug) $202.89
- TYSABRI (Biological) $188.96
- EMGALITY (Drug) $161.14
- WATCHMAN Access System (Device) $147.25
- APTIOM (Drug) $141.62
- PRALUENT (Drug) $139.44
- Actemra (Biological) $125.77
- AUBAGIO (Drug) $116.78
- OCREVUS (Biological) $116.41
- NAMZARIC (Drug) $115.36
- AJOVY (Drug) $112.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.